RxDoctor Payments Data

George Adams, MD

Internal Medicine · Knoxville, TNNPI 1083860506

Payments from drug & device makers

$4,539in general payments, 2019–2025

Across 284 payments — averaging $15.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$872
  • Amgen$757
  • AbbVie$600
  • Abbott$573
  • GSK$376
  • AstraZeneca$222
  • plus $1K from 23 others

What the payments were for

  • Food & beverage$4,539100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,539 in reported general payments places this provider in the 85th percentile of 2,216 internal medicine providers in Tennessee.

See all internal medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$115,386
Medicare patients
261
Services billed
3,983

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban66$84,601
MounjaroTirzepatide34$51,472
OzempicSemaglutide22$30,452
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$25,971
ShingrixVaricella-Zoster Ge/As01b/Pf68$15,411
XareltoRivaroxaban16$14,739
JanumetSitagliptin Phos/Metformin Hcl15$9,368
ArexvyRsvpref3 Antigen/As01e/Pf28$9,142
MyrbetriqMirabegron11$8,498
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$8,400
FarxigaDapagliflozin Propanediol11$7,828
Albuterol Sulfate HfaAlbuterol Sulfate147$5,261
Breo ElliptaFluticasone/Vilanterol11$5,090
Rosuvastatin Calcium525$4,468
Fluticasone-SalmeterolFluticasone Propion/Salmeterol12$4,149

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$193$84,60166 claims
GSKTrelegy Ellipta, Shingrix, Arexvy, Breo Ellipta$376$55,614139 claims
Lilly USA, LLCMounjaro$177$51,47234 claims
Novo NordiskOzempic$872$30,45222 claims
AstraZenecaBreztri Aerosphere, Farxiga$222$16,22825 claims
Johnson & JohnsonXarelto$32$14,73916 claims
MerckJanumet$15$9,36815 claims
Astellas Pharma US IncMyrbetriq$48$8,49811 claims
Sanofi-aventis U.S. LLCLantus$58$2,47719 claims
AbbVieSynthroid$600$2,33245 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,216 internal medicine providers in Tennessee.

Other internal medicine in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →